Omalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin EOmalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin EOmalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin EOmalizumab inhibits acceleration of FceRI-mediated responsiveness of immature human mast cells by immunoglobulin E